| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 01/08/2003 | EP1272484A2 Benzoamide piperidine compounds as substance p antagonists |
| 01/08/2003 | EP1272481A1 4-fluoroalkyl-2h-benzopyrans with anti-estrogenic activity |
| 01/08/2003 | EP1272470A1 Amorphous torasemide modification |
| 01/08/2003 | EP1272468A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 01/08/2003 | EP1272467A1 Cathepsin cysteine protease inhibitors |
| 01/08/2003 | EP1272465A2 Compounds and methods to increase plasma hdl cholesterol levels and improve hdl functionality |
| 01/08/2003 | EP1272455A1 Halogenated 2-amino-4, 5 heptenoic acid derivatives useful as nitric oxide synthase inhibitors |
| 01/08/2003 | EP1272219A1 New combination of a betablocker and a cholesterol-lowering agent |
| 01/08/2003 | EP1272201A2 Use of compatible solutes as substances having free radical scavenging properties |
| 01/08/2003 | EP1272185A2 Use of quinazoline derivatives as angiogenesis inhibitors |
| 01/08/2003 | EP1272175A2 Il-8 receptor antagonists |
| 01/08/2003 | EP1272172A2 Use of breakers of advanced glycation endproducts for treating deleterious effects of aging and debilitating diseases |
| 01/08/2003 | EP1272171A1 Synergistic compositions containing choline base and succinic acid for insulin resistance and diabetes |
| 01/08/2003 | EP1272169A2 Use of 13-hode as a regulator of vascular biocompatibility and an inhibitor of cell hyperplasia |
| 01/08/2003 | EP1272166A2 Pharmaceutical compositions comprising fluvastatin |
| 01/08/2003 | EP1272155A1 Use of natural substances in the production of cosmetic preparations |
| 01/08/2003 | EP1272060A2 Beta-glucan compositions for reducing hypercholesterolemia and controlling of postprandial blood glucose and insulin levels |
| 01/08/2003 | EP1272059A2 Method of producing oily suspensions of water-soluble vitamins |
| 01/08/2003 | EP1272049A1 Method for the fractionation of oil and polar lipid-containing native raw materials using alcohol and centrifugation |
| 01/08/2003 | EP1272048A2 Method for the fractionation of oil and polar lipid-containing native raw materials |
| 01/08/2003 | EP1080189A4 Compositions and methods for the synthesis of fatty acids, their derivatives and downstream products |
| 01/08/2003 | EP0984934B1 Novel orally active iron (iii) chelators |
| 01/08/2003 | EP0973515B1 Solid compositions suitable for oral administration comprising an alkanoyl-l-carnitine magnesium citrate |
| 01/08/2003 | EP0817646B1 Methods of treating inflammation and compositions therefor |
| 01/08/2003 | CN1390222A Imidazole compounds used as phosphodiesterase VII inhibitors |
| 01/08/2003 | CN1390220A Kinase inhibitors as therapeutic agents |
| 01/08/2003 | CN1390219A Pyrazolopyrimidines as therapeutic agents |
| 01/08/2003 | CN1390213A Aryloxy propanolamines for improving livestock production |
| 01/08/2003 | CN1390137A A Blocking monoclonal antibody to VLA-1 and its use for the treatment of inflammatory disorders |
| 01/08/2003 | CN1390131A Use of peptide |
| 01/08/2003 | CN1390126A Methods of treating and/or suppressing weight gain |
| 01/08/2003 | CN1390125A High lipid diet |
| 01/08/2003 | CN1390118A Dextrose and insulin fluid formulation for intravenous infusion |
| 01/08/2003 | CN1390096A Compositions, Kits and methods for providing and maintaining energy and mental alertness |
| 01/08/2003 | CN1389267A Recipe and prepn. of medicine for treating diabetes and ulcer |
| 01/08/2003 | CN1389263A Compound ginkgo capsule |
| 01/08/2003 | CN1389235A Diabetes treating medicine powder |
| 01/08/2003 | CN1389226A Arborescent aloe granule |
| 01/08/2003 | CN1389225A Diabetes treating Chinese medicine prepn. and its prepn. process |
| 01/08/2003 | CN1389196A Hypoglycemic skin care cream and its production process |
| 01/08/2003 | CN1389146A Blood sugar, blood pressure and blood fat depressing health food containing Qingqian willow extract |
| 01/08/2003 | CN1098256C Substd. benzenesulfonamide derivatives as prodrugs of COX-2 inhibitors |
| 01/08/2003 | CN1098084C Marine active substance and composition comprising the same |
| 01/08/2003 | CN1098070C Guanylhydrazones for treating inflammatory conditions |
| 01/07/2003 | US6504057 Fluorophenyl-substituted alkenylcarboxylic acid guanidides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 01/07/2003 | US6504005 Long-acting drugs and pharmaceutical compositions comprising them |
| 01/07/2003 | US6503931 Use of 4-amino pyridine for treatment of peripheral neuropathies |
| 01/07/2003 | US6503907 Indole and dihydroindole derivatives |
| 01/07/2003 | US6503900 [1,4]diazepino [6,7,1-jk ]carbazoles and derivatives |
| 01/07/2003 | US6503887 Peroral gene therapy of diabetes and obesity |
| 01/07/2003 | US6503713 Methods for identifying RNA binding compounds |
| 01/07/2003 | US6503543 Tryptophan source from plants and uses therefor |
| 01/07/2003 | US6503506 Nutrient therapy for immuno-compromised patients |
| 01/07/2003 | US6502789 Flexible kite |
| 01/05/2003 | CA2390181A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents |
| 01/03/2003 | WO2003001204A2 Type 1 diabetes diagnostics and therapeutics |
| 01/03/2003 | WO2003000896A2 POLYNUCLEOTIDES AND POLYPEPTIDES OF THE IFNα-5 GENE |
| 01/03/2003 | WO2003000886A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/03/2003 | WO2003000864A2 Nucleic acid-associated proteins |
| 01/03/2003 | WO2003000859A2 G-protein coupled receptors |
| 01/03/2003 | WO2003000712A1 Nitrogenous heterocyclic derivative, medicinal composition containing the same, medicinal use thereof, and intermediate therefor |
| 01/03/2003 | WO2003000697A1 Furoisoquinoline derivative, process for producing the same, and use |
| 01/03/2003 | WO2003000694A1 6-phenyldihydropyrrolopyrimidinedione derivatives |
| 01/03/2003 | WO2003000687A1 Tyrosine kinase inhibitors |
| 01/03/2003 | WO2003000685A1 5-membered heterocycle derivatives |
| 01/03/2003 | WO2003000684A1 Substituted naphthyl indole derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | WO2003000677A1 Spiropiperidine compounds as ligands for orl-1 receptor |
| 01/03/2003 | WO2003000671A1 Naphthyl benzofuran derivatives as inhibitors of plasminogen activator inhibitor-1 (pai-1) |
| 01/03/2003 | WO2003000666A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | WO2003000663A1 5-ht receptor ligands and uses thereof |
| 01/03/2003 | WO2003000649A1 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (pai-1) |
| 01/03/2003 | WO2003000295A2 Self-emulsifying formulations of cholesteryl ester transfer protein inhibitors |
| 01/03/2003 | WO2003000292A1 Pharmaceutical compositions comprising low-solubility and/or acid-sensitive drugs and neutralized acidic polymers |
| 01/03/2003 | WO2003000273A1 Modulating serum amyloid a interaction with tanis and agents useful for same |
| 01/03/2003 | WO2003000267A1 Amino nicotinate derivatives as glucokinase (glk) modulators |
| 01/03/2003 | WO2003000262A1 Vinyl phenyl derivatives as glk activators |
| 01/03/2003 | WO2003000250A1 3-fluoro-pyrrolidines as antidiabetic agents |
| 01/03/2003 | WO2003000249A1 Function regulator for retinoid relative receptor |
| 01/03/2003 | WO2003000248A1 Liquid composition |
| 01/03/2003 | WO2003000239A1 Stable pharmaceutical compositions containing pravastatin |
| 01/03/2003 | WO2003000238A1 Pharmaceutical compositions of adsorbates of amorphous drug |
| 01/03/2003 | WO2003000202A2 Particles for inhalation having rapid release properties |
| 01/03/2003 | WO2003000194A2 Thienopyridine and thienopyrimidine anticancer agents |
| 01/03/2003 | WO2003000185A2 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 01/03/2003 | WO2003000181A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2003000180A2 Dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 01/03/2003 | WO2003000178A2 Black soybean polysaccharides |
| 01/03/2003 | WO2003000177A2 Stable controlled release pharmaceutical compositions containing pravastatin |
| 01/03/2003 | WO2003000158A1 Pharmaceutical composition |
| 01/03/2003 | WO2003000075A1 Method for manufacturing of free-flowing powder containing water-dispersible sterols |
| 01/03/2003 | WO2003000021A2 Pancam nucleic acids and polypeptides |
| 01/03/2003 | WO2002083667A3 Inhibitors of c-jun n-terminal kinases (jnk) and other protein kinases |
| 01/03/2003 | WO2002080914A3 Use of substituted imidazo[1,2-a]-pyridine compounds as medicaments |
| 01/03/2003 | WO2002072584A3 Tetrahydro-pyrazino (1,2-a) indoles for the treatment of central nervous disorders |
| 01/03/2003 | WO2002066020A3 Modulation of gsk-3beta activity and its different uses |
| 01/03/2003 | WO2002056915A3 Complex of modafinil and cyclodextrin |
| 01/03/2003 | WO2002047673A3 Methods and compositions to treat conditions associated with neovascularization |
| 01/03/2003 | WO2002046170A8 Anilinopyrimidine derivatives as jnk pathway inhibitors and compositions and methods related thereto |
| 01/03/2003 | WO2002045754A3 Pharmaceutical compositions for the oral delivery of pharmacologically active agents |
| 01/03/2003 | WO2002034741A3 A NOVEL CRYSTALLINE FORM OF 6-HYDROXY-3-(4-[2-(PIPERIDIN-1-YL)ETHOXY]PHENOXY)-2-(4-METHOXYPHENYL)BENZO[b]THIOPHENE HYDROCHLORIDE |